Stephen Locarnini
Directeur/Bestuurslid bij BIOTRON LIMITED
Vermogen: 28 728 $ op 31-05-2024
Actieve functies van Stephen Locarnini
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
BIOTRON LIMITED | Directeur/Bestuurslid | 23-10-2018 | - |
Independent Dir/Board Member | 23-10-2018 | - | |
University of Melbourne
University of Melbourne Other Consumer ServicesConsumer Services The University of Melbourne, founded in 1853, is a world-renowned institution located in Parkville, Australia. The university is a leader in education, teaching, and research, offering a wide range of coursework and research programs. | Corporate Officer/Principal | - | - |
Loopbaan van Stephen Locarnini
Eerdere bekende functies van Stephen Locarnini
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
ClearB Therapeutics, Inc.
ClearB Therapeutics, Inc. BiotechnologyHealth Technology ClearB Therapeutics, Inc. is a company that focuses on therapeutics. The company is based in Concord, MA. The company was co-founded in 2017 by Morningside Ventures in collaboration with Professor Stephen Locarnini and the Victoria Infectious Diseases Reference Laboratory. Aileen Rubio has been the CEO of the company since 2018. | Oprichter | 01-01-2017 | - |
Victorian Infectious Diseases Reference Laboratory | Corporate Officer/Principal | 01-01-1990 | - |
World Health Organization Collaborating Centre | Directeur/Bestuurslid | - | - |
Statistieken
Internationaal
Australië | 5 |
Verenigde Staten | 2 |
Operationeel
Director/Board Member | 2 |
Corporate Officer/Principal | 2 |
Independent Dir/Board Member | 1 |
Sectoraal
Health Technology | 3 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
BIOTRON LIMITED | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
World Health Organization Collaborating Centre | |
ClearB Therapeutics, Inc.
ClearB Therapeutics, Inc. BiotechnologyHealth Technology ClearB Therapeutics, Inc. is a company that focuses on therapeutics. The company is based in Concord, MA. The company was co-founded in 2017 by Morningside Ventures in collaboration with Professor Stephen Locarnini and the Victoria Infectious Diseases Reference Laboratory. Aileen Rubio has been the CEO of the company since 2018. | Health Technology |
Victorian Infectious Diseases Reference Laboratory |
- Beurs
- Insiders
- Stephen Locarnini
- Ervaring